NCT04883827Completed
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
Monitoring Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
Source: ClinicalTrials.gov · Last updated 22 Oct 2024
Brief summary (registry, in English)
This study will assess whether DNA released by kidney cancer into the blood stream and urine of patients can be used to monitor tumor burden and tumor response to treatment in patients receiving immunotherapy
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 180 (actual)
- First submitted
- 6 May 2021
- Start date
- 6 Jan 2021
- Primary completion date
- 1 Dec 2023
- Lead sponsor
- Vanderbilt-Ingram Cancer Center
- Diseases
- Kidney cancer
- NCT number
- NCT04883827
What you commit to
- Study type: Observational
- Participants enrolled: 180
- From 6 Jan 2021 to the primary completion date, 1 Dec 2023
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Active cancer (exclusion criteria only for healthy patient cohort)
Who the study is looking for
- Renal Cell Carcinoma with clear cell component
- Stage IV
- Receiving IO-containing regimen
- Measurable disease per RECIST 1.1
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Texas MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
| Tennessee Valley Health Care System Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
| Vanderbilt University Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.